Class summary at a glance.

Every drug in the Low Molecular Weight Heparin class tracked across NADAC, Part D Formulary, Part D Spending, FDA Orange Book, and shortage data. Ranked below by CY24 Part D spend. Click any molecule for the full drug profile.

Molecules in class: 1tracked in Part D
CY24 Part D spend: $118.4Mcombined across class
Total Rx claims: 803K439K unique beneficiaries
Generic mfrs (active): 9across all molecules

Every drug in this class, ranked by Part D spend.

CY2024 dataCMS Part D Spending Dashboard

Enoxaparin

Brand: Lovenox · 803K Part D claims (CY24) · 439K beneficiaries · First FDA approval: 1993-03-29

9 generic mfrs 0 plans require PA

Low NADAC$6.78

→

Avg plan cost$9.50

Part D spend $118.4M 1× spread, current vs floor

Class share

100%

of class CY24 spend

View profile →

Class summary at a glance.

Every drug in this class, ranked by Part D spend.

Related questions.